ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,628 | +26.1% | 60 | +42.9% | 0.00% | – |
| Q2 2023 | $1,291 | -99.2% | 42 | -99.0% | 0.00% | – |
| Q1 2023 | $155,541 | -99.4% | 4,317 | -99.4% | 0.00% | -100.0% |
| Q4 2022 | $26,372,880 | -47.7% | 667,330 | -46.9% | 0.04% | -49.4% |
| Q3 2022 | $50,458,000 | +34.3% | 1,255,804 | +40.5% | 0.09% | +41.3% |
| Q2 2022 | $37,576,000 | +5893.0% | 893,835 | +5445.9% | 0.06% | +6200.0% |
| Q1 2022 | $627,000 | -39.8% | 16,117 | -38.4% | 0.00% | 0.0% |
| Q4 2021 | $1,042,000 | – | 26,156 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |